They also increased the size of their study. Both
Post# of 148278
(Total Views: 500)
Posted On: 08/05/2020 2:35:51 PM
Re: Coocooburra #47312
They also increased the size of their study. Both of those are not good signs for Lenzi. And, give further credence to the DSMC tellling us to continue.
Leronlimab is clearly working in the S/C trial. I believe that in the world that these folks live in (FDA, DSMC, etc) that we are so close to Interim analysis, that a stoppage was incredibly unlikely.
We just need to get the enrollment completed and the 28 day clock started.
Leronlimab is clearly working in the S/C trial. I believe that in the world that these folks live in (FDA, DSMC, etc) that we are so close to Interim analysis, that a stoppage was incredibly unlikely.
We just need to get the enrollment completed and the 28 day clock started.
(11)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼